Research published in Cell Reports Medicine in 2026 concluded directly: weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function
News & World Report, patients frequently face delays, denials, and administrative hurdles while attempting to secure approval for GLP-1 prescriptions
Indeed, stimulation of glycolytic flux in cultured astrocytes was observed due to exposure to the primary metabolite of Efavirenz (Brandmann et al
While PT-141 is still being studied, it has shown some promise as a potential treatment for sexual dysfunction and other conditions
Always follow your doctors instructions carefully
Ungar, PhD, a professor at Penn Engineering, notes that while clinical trials are excellent at flagging high-risk safety concerns, they often overlook the day-to-day symptoms that bother patients the most